eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Check drugs       Compare drugs       Join a support group

A study for a 56-year old man who takes Meloxicam, Methocarbamol

Summary: 14 male patients aged 56 (±5) who take the same drugs are studied.

This is a personalized study for a 56 year old male patient who has Pain. The study is created by eHealthMe based on reports from FDA and social media.

 

On Feb, 26, 2015: 14 males aged 51 (±5) who take Meloxicam, Methocarbamol are studied

Meloxicam, Methocarbamol outcomes

Information of the patient in this study:

Age: 51

Gender: male

Conditions: Pain

Drugs taking:
- Meloxicam - 7.5MG (meloxicam): used for < 1 month
- Methocarbamol - 750MG (methocarbamol)

Comments from or about the patient: can methocarbamol be taken less than 24 hours after meloxicam
Reply the comment

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

InteractionNumber of reports on eHealthMe
MethocarbamolThe drug has been added in the study. Outcomes of the drug mix are shown.

Drug effectiveness over time :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Meloxicam is effective0.00%
(0 of 1 people)
n/an/an/an/an/an/an/a
Methocarbamol is effectiven/an/an/an/an/an/an/an/a

Most common drug interactions over time * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Psychotic Disordern/an/an/an/an/an/aBack Pain
Delusion (a false belief or opinion)Abdominal Pain
Renal Failure Acute (rapid kidney dysfunction)Headache (pain in head)
Hypertension (high blood pressure)Pain
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)Pyrexia (fever)
Thrombocytopenia (decrease of platelets in blood)Fatigue (feeling of tiredness)
Hepatic Enzyme Increased
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Depression
Chest Discomfort

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

 

 

 

You are not alone! Join a related support group:
- support group for people who have Pain
- support group for people who take Meloxicam
- support group for people who take Methocarbamol

Recent related drug studies (Check your drugs):

Related drug interaction studies:

Drug effectiveness in real world:

Complete drug side effects:

Alternative drugs:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us - eHealth.me

 
© 2015 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.